Status:
WITHDRAWN
Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)
Lead Sponsor:
Asociación para Evitar la Ceguera en México
Conditions:
Cystoid Macular Edema
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
To report safety and efficacy of intravitreal injection of bevacizumab in patients with cystoid macular edema secondary to cataract surgery.
Eligibility Criteria
Inclusion
- Pseudophakic eyes with macular edema
Exclusion
- Other retinopathies
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00406172
Start Date
November 1 2006
End Date
November 1 2006
Last Update
June 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
APEC
México D.F., Mexico, 03040